Anavex Life Sciences Future Growth
Future criteria checks 0/6
Anavex Life Sciences is forecast to grow earnings at 6.9% per annum. EPS is expected to grow by 10.5% per annum.
Key information
6.9%
Earnings growth rate
10.5%
EPS growth rate
Biotechs earnings growth | 26.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 15 Feb 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2026 | N/A | -32 | N/A | N/A | 1 |
9/30/2025 | N/A | -55 | N/A | N/A | 2 |
9/30/2024 | N/A | -47 | N/A | N/A | 2 |
12/31/2023 | N/A | -43 | -29 | -29 | N/A |
9/30/2023 | N/A | -48 | -28 | -28 | N/A |
6/30/2023 | N/A | -52 | -26 | -26 | N/A |
3/31/2023 | N/A | -53 | -25 | -25 | N/A |
12/31/2022 | N/A | -50 | -27 | -27 | N/A |
9/30/2022 | N/A | -48 | -24 | -24 | N/A |
6/30/2022 | N/A | -45 | -28 | -28 | N/A |
3/31/2022 | N/A | -43 | -28 | -28 | N/A |
12/31/2021 | N/A | -41 | -26 | -26 | N/A |
9/30/2021 | N/A | -38 | -30 | -30 | N/A |
6/30/2021 | N/A | -32 | -29 | -29 | N/A |
3/31/2021 | N/A | -28 | -25 | -25 | N/A |
12/31/2020 | N/A | -28 | -23 | -23 | N/A |
9/30/2020 | N/A | -26 | -21 | -21 | N/A |
6/30/2020 | N/A | -26 | -18 | -18 | N/A |
3/31/2020 | N/A | -26 | -21 | -21 | N/A |
12/31/2019 | N/A | -26 | -20 | -20 | N/A |
9/30/2019 | N/A | -26 | -19 | -19 | N/A |
6/30/2019 | N/A | -26 | -20 | -20 | N/A |
3/31/2019 | N/A | -23 | -15 | -15 | N/A |
12/31/2018 | N/A | -20 | -13 | -13 | N/A |
9/30/2018 | N/A | -17 | -13 | -13 | N/A |
6/30/2018 | N/A | -17 | -11 | -11 | N/A |
3/31/2018 | N/A | -18 | -12 | -12 | N/A |
12/31/2017 | N/A | -14 | -9 | -9 | N/A |
9/30/2017 | N/A | -13 | N/A | -9 | N/A |
6/30/2017 | N/A | -15 | N/A | -9 | N/A |
3/31/2017 | N/A | -13 | N/A | -8 | N/A |
12/31/2016 | N/A | -14 | N/A | -9 | N/A |
9/30/2016 | N/A | -15 | N/A | -9 | N/A |
6/30/2016 | N/A | -14 | N/A | -9 | N/A |
3/31/2016 | N/A | -16 | N/A | -8 | N/A |
12/31/2015 | N/A | -15 | N/A | -7 | N/A |
9/30/2015 | N/A | -12 | N/A | -4 | N/A |
6/30/2015 | N/A | -15 | N/A | -4 | N/A |
3/31/2015 | N/A | -12 | N/A | -3 | N/A |
12/31/2014 | N/A | -11 | N/A | -3 | N/A |
9/30/2014 | N/A | -10 | N/A | -3 | N/A |
6/30/2014 | N/A | -5 | N/A | -2 | N/A |
3/31/2014 | N/A | -4 | N/A | -1 | N/A |
12/31/2013 | N/A | -3 | N/A | -1 | N/A |
9/30/2013 | N/A | -4 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0HFR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0HFR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0HFR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if 0HFR's revenue is forecast to grow faster than the UK market.
High Growth Revenue: 0HFR is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0HFR's Return on Equity is forecast to be high in 3 years time